Xu et al. (2020) reported in their study that silencing GGCT not only affects the proliferation, invasion and migration abilities of endometrial carcinoma but also regulates the expression of PD-L1, thereby enhancing the killing capability of CD8 + T lymphocytes against tumor cells. This evidence concerns the gene CD8A and endometrial carcinoma.